Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Isolation of Bacillus amyloliquefaciens M13-RW0 from Soil and Evaluation of its Antifungal Activity

Author(s): Shirin Naghdifar, Mahboobeh Madani* and Pegah Shakib*

Volume 20, Issue 4, 2023

Published on: 10 May, 2023

Article ID: e190423216028 Pages: 7

DOI: 10.2174/1570163820666230419090347

Price: $65

Abstract

Background: The frequency of observed invasive Aspergillosis has increased in recent years. Infection with other molds happens but does not lead to a large proportion of invasive infections. The present study aims to isolate Bacillus amyloliquefaciens M13-RW0 from soil and evaluate its antifungal effects against some saprophytic fungi, such as Aspergillus niger, Aspergillus flavus, and Mucor hiemalis.

Materials and Methods: In this research, a total of 150 samples (from the soil, air, and surfaces) were prepared from different parts of Isfahan, Iran. Isolation and purification of growing bacteria were conducted using the nutrient agar medium. The inhibitory effects of 100 isolated bacteria were evaluated against the growth of A. niger, A. flavus, and M. hiemalis, 4 bacteria were isolated with inhibitory effects against the selected fungi, and consequently, one of the bacteria isolated from the soil samples was found to show the highest inhibition of fungal growth. Quantitative evaluation of the growth inhibitory effect was performed using linear culturing of fungal suspension (104 spore/ml) at distances of 5, 10, 15, 20, 25, and 30mm from bacterial isolate (0.5 McFarland) on Sabouraud Dextrose Agar (SDA) medium. Results were checked 24, 48, 72, and 96 hours later. The bacterial isolate with the most inhibitory effect was identified by phenotypic and molecular tests.

Results: According to the results, among the 4 inhibitory bacterial isolates, Bacillus amyloliquefaciens strain M13-RW01, isolated from the soil samples, was identified as the bacterium with the most significant potential antifungal activity. The strong inhibitory effect was revealed after 48 hours for all distances of 15mm and more between the fungi and the bacterium.

Conclusion: The identified bacterium could not only be considered an inhibitor bacterium against saprophytic fungi but could also be put forward to help produce new antifungal drugs for controlling fungal diseases.

[1]
Ranjbariyan A, Shams-Ghahfarokhi M, Kalantari S, Razzaghi-Abyaneh M. Molecular identification of antagonistic bacteria from Tehran soils and evaluation of their inhibitory activities toward pathogenic fungi. Iran J Microbiol 2011; 3(3): 140-6.
[PMID: 22347597]
[2]
Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. 1988; 63(10): p1061-1062.
[3]
Gupta KL, Gupta A. Mucormycosis and acute kidney injury. J Nephropathol 2012; 1(3): 155-9.
[http://dx.doi.org/10.5812/nephropathol.8111] [PMID: 24475407]
[4]
Jalili M, Hatami A, Kalantari H, Kalantar EJSPJ. Mutagenicity assessment of two herbal medicines, Urtan and Carmint in human leukocytes by single cell gel electrophoresis. Saudi Pharm J 2006; 14(2): 129-31.
[5]
Kalantari H, Larki A, Latifi S. The genotoxicity study of garlic and pasipy herbal drops by peripheral blood micronucleus test. Acta Physiol Hung 2007; 94(3): 261-6.
[http://dx.doi.org/10.1556/APhysiol.94.2007.3.10] [PMID: 17853777]
[6]
Yamaguchi IJCROAC. Pesticides of microbial origin and applications of molecular biology. Mol Biol Rep 1996; 35: 27-49.
[7]
Al-Bayati FA, Al-Mola HF. Antibacterial and antifungal activities of different parts of Tribulus terrestris L. growing in Iraq. J Zhejiang Univ Sci B 2008; 9(2): 154-9.
[http://dx.doi.org/10.1631/jzus.B0720251] [PMID: 18257138]
[8]
Munimbazi C, Bullerman LB. Isolation and partial characterization of antifungal metabolites of Bacillus pumilus. J Appl Microbiol 1998; 84(6): 959-68.
[http://dx.doi.org/10.1046/j.1365-2672.1998.00431.x] [PMID: 9717280]
[9]
Kalantar E. Minimizing potential resistance among bacteria causing urinary tract infection. J Nephropathol 2012; 1(1): 11-2.
[http://dx.doi.org/10.5812/jnp.3] [PMID: 24475380]
[10]
Cherif A, Sadfi-Zouaoui N, Eleuch D, Ben Osman Dhahri A, Boudabous A. Pseudomonas isolates have in vitro antagonistic activity against the dermatophytes Trichophyton rubrum, Trichophyton mentagrophytes var interdigitale and Microsporum canis. J Mycol Med 2009; 19(3): 178-84.
[http://dx.doi.org/10.1016/j.mycmed.2009.05.001]
[11]
Lange L, Sanchez Lopez CJCROAC. Micro-organisms as a source of biologically active secondary metabolites 1996; 35: 1-26.
[12]
Dezfully NK, Ramanayaka JG. Isolation, identification and evaluation of antimicrobial activity of Streptomyces flavogriseus, strain ACTK2 from soil sample of Kodagu, Karnataka State (India). Jundishapur J Microbiol 2015; 8(2): e15107.
[13]
Milner JL, Silo-Suh L, Lee JC, He H, Clardy J, Handelsman J. Production of kanosamine by Bacillus cereus UW85. Appl Environ Microbiol 1996; 62(8): 3061-5.
[http://dx.doi.org/10.1128/aem.62.8.3061-3065.1996] [PMID: 8702302]
[14]
Napoli C, Marcotrigiano V, Montagna MT. Air sampling procedures to evaluate microbial contamination: A comparison between active and passive methods in operating theatres. BMC Public Health 2012; 12(1): 594.
[http://dx.doi.org/10.1186/1471-2458-12-594]
[15]
Poletti L, Pasquarella C, Pitzurra M, Savino A. Comparative efficiency of nitrocellulose membranes versus RODAC plates in microbial sampling on surfaces. J Hosp Infect 1999; 41(3): 195-201.
[http://dx.doi.org/10.1016/S0195-6701(99)90016-6] [PMID: 10204121]
[16]
Ceylan O, Okmen G, Ugur A. Isolation of soil Streptomyces as source antibiotics active against antibiotic-resistant bacteria. EurAsia J BioSc 2008; 2: 73-82.
[17]
Hua SST, Baker JL, Flores-Espiritu M, Microbiology E. Interactions of saprophytic yeasts with a nor mutant of Aspergillus flavus. Appl Environ Microbiol 1999; 65(6): 2738-40.
[http://dx.doi.org/10.1128/AEM.65.6.2738-2740.1999] [PMID: 10347069]
[18]
Ghorbani A, Ehsanpour A, Roshanzamir N, Omidvar B. Alterations in antibiotic susceptibility of urinary tract infection pathogens. J Nephropathol 2012; 1(1): 43-8.
[http://dx.doi.org/10.5812/jnp.8] [PMID: 24475385]
[19]
Alavi SM, Sharifi M, Eghtesad M. Bacterial sepsis: challenges of diagnosis and treatment in a teaching hospital southwest of Iran. Jundishapur J Microbiol 2014; 7(3): e9082.
[http://dx.doi.org/10.5812/jjm.9082] [PMID: 25147683]
[20]
Vicente MF, Basilio A, Cabello A. Peláez F. Microbial natural products as a source of antifungals. Clin Microbiol Infect 2003; 9(1): 15-32.
[http://dx.doi.org/10.1046/j.1469-0691.2003.00489.x] [PMID: 12691539]
[21]
Gohari A-R, Saeidnia S. The role of herbal medicines in treatment of urinary tract diseases. J Nephropharmacol 2014; 3(1): 13-4.
[PMID: 28197453]
[22]
Cronin D, Moënne-Loccoz Y, Fenton A, Dunne C, Dowling DN, O’Gara F. Ecological interaction of a biocontrol Pseudomonas fluorescens strain producing 2,4-diacetylphloroglucinol with the soft rot potato pathogen Erwinia carotovora subsp. atroseptica. FEMS Microbiol Ecol 1997; 23(2): 95-106.
[http://dx.doi.org/10.1111/j.1574-6941.1997.tb00394.x]
[23]
Svanström Å, Boveri S, Boström E, Melin P. The lactic acid bacteria metabolite phenyllactic acid inhibits both radial growth and sporulation of filamentous fungi. BMC Res Notes 2013; 6(1): 464.
[http://dx.doi.org/10.1186/1756-0500-6-464] [PMID: 24229396]
[24]
Ongena M, Jacques P. Bacillus lipopeptides: Versatile weapons for plant disease biocontrol. Trends Microbiol 2008; 16(3): 115-25.
[http://dx.doi.org/10.1016/j.tim.2007.12.009] [PMID: 18289856]
[25]
Narayana KJ, Prabhakar P, Vijayalakshmi M, Venkateswarlu Y, Krishna PS. Biological activity of phenylpropionic acid isolated from a terrestrial Streptomycetes. Pol J Microbiol 2007; 56(3): 191-7.
[PMID: 18062653]
[26]
Yuan J, Raza W, Shen Q, Huang Q. Antifungal activity of bacillus amyloliquefaciens njn-6 volatile compounds against Fusarium oxysporum f. sp. cubense. Appl Environ Microbiol 2012; 78(16): 5942-4.
[http://dx.doi.org/10.1128/AEM.01357-12] [PMID: 22685147]
[27]
Khan N, Martínez-Hidalgo P. Ice TA et al Antifungal activity of Bacillus species against Fusarium and analysis of the potential mechanisms used in biocontrol. Front Microbiol 2018; 9: 2363.
[http://dx.doi.org/10.3389/fmicb.2018.02363] [PMID: 30333816]
[28]
Cesa-Luna C, Baez A, Aguayo-Acosta A, et al. Growth inhibition of pathogenic microorganisms by Pseudomonas protegens EMM-1 and partial characterization of inhibitory substances. PLoS One 2020; 15(10): e0240545.
[http://dx.doi.org/10.1371/journal.pone.0240545] [PMID: 33057351]
[29]
Saleh AE, Ul-Hassan Z, Zeidan R, et al. Biocontrol activity of Bacillus megaterium BM344-1 against toxigenic fungi. ACS Omega 2021; 6(16): 10984-90.
[http://dx.doi.org/10.1021/acsomega.1c00816] [PMID: 34056251]
[30]
Li S, Xu X, Zhao T, et al. Screening of Bacillus velezensis E2 and the inhibitory effect of its antifungal substances on Aspergillus flavus. Foods 2022; 11(2): 140.
[http://dx.doi.org/10.3390/foods11020140] [PMID: 35053872]
[31]
Chitarra GS, Breeuwer P, Nout MJR, van Aelst AC, Rombouts FM, Abee T. An antifungal compound produced by Bacillus subtilis YM 10-20 inhibits germination of Penicillium roqueforti conidiospores. J Appl Microbiol 2003; 94(2): 159-66.
[http://dx.doi.org/10.1046/j.1365-2672.2003.01819.x] [PMID: 12534806]
[32]
Kugler M, Loeffler W, Rapp C, Kern A, Jung G. Rhizocticin A, an antifungal phosphono-oligopeptide of Bacillus subtilis ATCC 6633: Biological properties. Arch Microbiol 1990; 153(3): 276-81.
[http://dx.doi.org/10.1007/BF00249082] [PMID: 2110446]
[33]
Stabb EV, Jacobson LM, Handelsman J, Microbiology E. Zwittermicin A-producing strains of Bacillus cereus from diverse soils. Appl Environ Microbiol 1994; 60(12): 4404-12.
[http://dx.doi.org/10.1128/aem.60.12.4404-4412.1994] [PMID: 7811080]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy